fda warning bpc-157 compounding peptides FDA's Overreach on Compounded Exciting news for peptides coming fda warning bpc 157 safety

Research note: A 2025 literature and patent review catalogued BPC-157's multifunctional activity across gastrointestinal, musculoskeletal, neurological, and cardiovascular preclinical models

On the other hand, for the L-NAME retrobulbar applicationinduced retinal ischemia model and BPC 157 therapy in rats, we should emphasize the point that animal studies per se may be cautious regarding their results, although the role of an animal model is indispensable (Minhas et al., 2015

27 May 2016

Expectation misalignment Expecting dramatic results in the first week sets up disappointment

What the Science Actually Shows on AOD-9604 Research on AOD9604 has produced mixed results